KRAS and colorectal carcinoma: For 12 patients with KRAS mutant CRC, 10 (83.3%) had positive cfDNA analysis (Figure 1C), and the same KRAS mutation was detected in the cfDNA of eight patients (66.7%; Figure 1A).